A rare duplication variant of A2ML1 (α2-macroglobulin-like 1), a gene encoding a middle-ear specific protease inhibitor, has been identified to confer an increased susceptibility to OM (Santos-Cortez et al., 2015). Here, A2ML1 is linked to ocular melanoma.